Greco Hernández

Dr. Greco Hernández

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Trends in Biochemical Sciences
Verified
Journal Article
Open access
Greco HernándezGreco Hernández
Greco Hernández
VOVincent G. Osnaya
Vincent G. Osnaya
XPXochitl Pérez-Martínez
Xochitl Pérez-Martínez
Selection of the translation initiation site (TIS) is a crucial step during translation. In the 1980s Marylin Kozak performed key studies on vertebrate mRNAs to characterize the optimal TIS consensus sequence, the Kozak motif. Within this motif, conservation of nucleotides in crucial positions, namely a purine at -3 and a G at +4 (where the A of the AUG is numbered +1), is essential for TIS recognition. Ever since its characterization the Kozak motif has been regarded as the optimal sequence to initiate translation in all eukaryotes. We revisit here published in silico data on TIS consensus sequences, as well as experimental studies from diverse eukaryotic lineages, and propose that, while the -3A/G position is universally conserved, the remaining variability of the consensus sequences enables their classification as optimal, strong, and moderate TIS sequences.

25 July 2019
Verified
Book Chapter
Closed access
PDF file
MVMitzli X. Velasco
Mitzli X. Velasco
AKAdam Kosti
Adam Kosti
Luiz PenalvaLuiz Penalva
Luiz Penalva
Greco HernándezGreco Hernández
Greco Hernández

13 March 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
PAPilar Sarah Acevo-Rodríguez
Pilar Sarah Acevo-Rodríguez
GMGiovanna Maldonado
Giovanna Maldonado
SCSusana Castro-Obregón
Susana Castro-Obregón
Greco HernándezGreco Hernández
Greco Hernández
Various metabolic pathways and molecular processes in the cell act intertwined, and dysregulating the interplay between some of them may lead to cancer. It is only recently that defects in the translation process, i.e., the synthesis of proteins by the ribosome using a messenger (m)RNA as a template and translation factors, have begun to gain strong attention as a cause of autophagy dysregulation with effects in different maladies, including cancer. Autophagy is an evolutionarily conserved catabolic process that degrades cytoplasmic elements in lysosomes. It maintains cellular homeostasis and preserves cell viability under various stress conditions, which is crucial for all eukaryotic cells. In this review, we discuss recent advances shedding light on the crosstalk between the translation and the autophagy machineries and its impact on tumorigenesis. We also summarize how this interaction is being the target for novel therapies to treat cancer.

30 January 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
Greco HernándezGreco Hernández
Greco Hernández
JRJorge L. Ramírez
Jorge L. Ramírez
APAbraham Pedroza-Torres
Abraham Pedroza-Torres
LHLuis A. Herrera
Luis A. Herrera
MJMiguel A. Jiménez-Ríos
Miguel A. Jiménez-Ríos
Prostate cancer (PCa) is the second most prevalent cancer in men worldwide. Despite the advances understanding the molecular processes driving the onset and progression of this disease, as well as the continued implementation of screening programs, PCa still remains a significant cause of morbidity and mortality, in particular in low-income countries. It is only recently that defects of the translation process, i.e., the synthesis of proteins by the ribosome using a messenger (m)RNA as a template, have begun to gain attention as an important cause of cancer development in different human tissues, including prostate. In particular, the initiation step of translation has been established to play a key role in tumorigenesis. In this review, we discuss the state-of-the-art of three key aspects of protein synthesis in PCa, namely, misexpression of translation initiation factors, dysregulation of the major signaling cascades regulating translation, and the therapeutic strategies based on pharmacological compounds targeting translation as a novel alternative to those based on hormones controlling the androgen receptor pathway.

1 December 2020 in Journal of Molecular Biology
Verified
Journal Article
Closed access
Greco HernándezGreco Hernández
Greco Hernández
AGAlejandra García
Alejandra García
NSNahum Sonenberg
Nahum Sonenberg
PLPaul Lasko
Paul Lasko

14 May 2012 in Comparative and Functional Genomics
Verified
Journal Article
Open access
PDF file
Greco HernándezGreco Hernández
Greco Hernández
CPChristopher Proud
Christopher Proud
Thomas PreissThomas Preiss
Thomas Preiss
APArmen Parsyan
Armen Parsyan
Diversity is one of the most remarkable features of living organisms. Current assessments of eukaryote biodiversity reaches 1.5 million species, but the true figure could be several times that number. Diversity is ingrained in all stages and echelons of life, namely, the occupancy of ecological niches, behavioral patterns, body plans and organismal complexity, as well as metabolic needs and genetics. In this review, we will discuss that diversity also exists in a key biochemical process, translation, across eukaryotes. Translation is a fundamental process for all forms of life, and the basic components and mechanisms of translation in eukaryotes have been largely established upon the study of traditional, so-called model organisms. By using modern genome-wide, high-throughput technologies, recent studies of many nonmodel eukaryotes have unveiled a surprising diversity in the configuration of the translation apparatus across eukaryotes, showing that this apparatus is far from being evolutionarily static. For some of the components of this machinery, functional differences between different species have also been found. The recent research reviewed in this article highlights the molecular and functional diversification the translational machinery has undergone during eukaryotic evolution. A better understanding of all aspects of organismal diversity is key to a more profound knowledge of life.